Strongest fit
Who it is built for
- Biopharma teams developing small-molecule therapeutics
- Drug-discovery researchers exploring molecular design space
- Partners pursuing AI-enabled discovery programs
Iambic Therapeutics
AI-driven discovery of small-molecule medicines
Iambic Therapeutics is the current name for Entos. Its proprietary drug-discovery platform combines AI technologies, including Enchant and NeuralPLexer, with high-throughput experimentation to explore chemical space, generate molecular designs, and develop small-molecule therapeutic candidates for its internal pipeline and partners.
ITIambic TherapeuticsProduct screenshot pending
- Best for
- Biopharma teams developing small-molecule therapeutics
- Pricing signal
- Not publicly listed
- Primary category
- Drug discovery
- Last verified
- Jul 30, 2026
The decision
Should Iambic Therapeutics make your shortlist?
Start with the job, the team, and the constraints. Product fit becomes much clearer when those three line up.
Practical use cases
Jobs it can take on
- Explore chemical space for novel mechanisms of action
- Generate biological insights from new molecular designs
- Advance differentiated small-molecule drug candidates
Before you choose
Know the tradeoffs
- Iambic presents its discovery platform as proprietary rather than as a public self-service software product.
Inside the product
What you can actually do with it.
The core product capabilities, grouped around the work they enable.
AI discovery technologies
Iambic uses its Enchant and NeuralPLexer technologies for multimodal and co-folding analysis in drug discovery.
High-throughput experimentation
The platform converts new molecular designs into biological insights through AI-driven experimental workflows.
Therapeutic pipeline
Iambic applies its platform to a proprietary pipeline of differentiated clinical and preclinical drug candidates.
Typical workflow
Iambic uses AI technologies to explore molecular designs and identify candidate mechanisms of action. Its high-throughput experimental platform generates biological data that informs the advancement of therapeutic candidates.
Plans and official links
Plans and accessNot publicly listed.
See the entry price, free access options, company details, and direct vendor destinations in one place.
Starting pointNot publicly listed
- Provider
- Iambic Therapeutics, Inc.
- Based in
- US
- Founded
- 2019
Official destinations
Choosing for a real workflow?
Make the tool work with the rest of your operation.
We map the workflow, connect existing systems, choose what to buy, and build what is missing.